CINDY CHAPMAN: Open Payments
NPI 1104410968 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 51 payments from 18 companies in 2025. Trend: 2023 $595 · 2024 $444 · 2025 $1,222
Food & beverage: $1,206Education: $16
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 11 | $226 |
| Amgen Inc. | 10 | $147 |
| Novartis Pharmaceuticals Corporation | 3 | $126 |
| Ardelyx, Inc. | 2 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $113 |
| Calliditas Therapeutics US Inc. | 3 | $83 |
| Novo Nordisk Inc | 3 | $75 |
| Travere Therapeutics, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Lilly USA, LLC | 2 | $33 |
Products named: VELPHORO, KRYSTEXXA, XPHOZAH 30 MG, Vanrafia, JYNARQUE, TARPEYO, Ozempic, FARXIGA.
Industry payments across IN — which companies pay providers there.
